<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Clerkin KJ</submitter><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><pagination>12-23</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8724562</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>This analysis sought to investigate the waitlist and post-transplant outcomes of individuals bridged to transplantation by using temporary percutaneous endovascular mechanical circulatory support (tMCS) through a status 2 designation (cardiogenic shock and exception).&lt;h4>Background&lt;/h4>The 2018 donor heart allocation policy change granted a status 2 designation to patients supported with tMCS.&lt;h4>Methods&lt;/h4>Adult patients in the United Network for Organ Sharing registry after October 18, 2018 who received a status 2 designation for tMCS were included and grouped by their status 2 criteria: cardiogenic shock with hemodynamic criteria (CS-HD), cardiogenic shock without hemodynamic criteria before tMCS (CS-woHD), and exception. Baseline characteristics, waitlist events (de</pubmed_abstract><journal>JACC. Heart failure</journal><pubmed_title>Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System.</pubmed_title><pmcid>PMC8724562</pmcid><funding_grant_id>K23 HL148528</funding_grant_id><pubmed_authors>Clerkin KJ</pubmed_authors><pubmed_authors>Jain R</pubmed_authors><pubmed_authors>Salako O</pubmed_authors><pubmed_authors>Colombo PC</pubmed_authors><pubmed_authors>Topkara VK</pubmed_authors><pubmed_authors>Farr MA</pubmed_authors><pubmed_authors>Uriel N</pubmed_authors><pubmed_authors>Restaino S</pubmed_authors><pubmed_authors>Griffin JM</pubmed_authors><pubmed_authors>Fried JA</pubmed_authors><pubmed_authors>Takeda K</pubmed_authors><pubmed_authors>Sayer G</pubmed_authors><pubmed_authors>Raikhelkar J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System.</name><description>&lt;h4>Objectives&lt;/h4>This analysis sought to investigate the waitlist and post-transplant outcomes of individuals bridged to transplantation by using temporary percutaneous endovascular mechanical circulatory support (tMCS) through a status 2 designation (cardiogenic shock and exception).&lt;h4>Background&lt;/h4>The 2018 donor heart allocation policy change granted a status 2 designation to patients supported with tMCS.&lt;h4>Methods&lt;/h4>Adult patients in the United Network for Organ Sharing registry after October 18, 2018 who received a status 2 designation for tMCS were included and grouped by their status 2 criteria: cardiogenic shock with hemodynamic criteria (CS-HD), cardiogenic shock without hemodynamic criteria before tMCS (CS-woHD), and exception. Baseline characteristics, waitlist events (de</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-19T18:07:30.128Z</modification><creation>2025-04-19T18:07:30.128Z</creation></dates><accession>S-EPMC8724562</accession><cross_references><pubmed>34969492</pubmed><doi>10.1016/j.jchf.2021.08.003</doi></cross_references></HashMap>